Related articles

  • Randomized Controlled Trial

    Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.

    Stroke. 2014 Apr 1;45(4):1000-6.

  • Randomized Controlled Trial

    Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial.

    Stroke. 2010 Apr 1;41(4):707-11.

  • Multicenter Study

    Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.

    J Stroke Cerebrovasc Dis. 2012 Nov 1;21(8):898-902.

    • Show more related articles...